AI Summary

Researchers at the Garvan Institute of Medical Research have shown that two closely related bowel diseases, which are presently managed with identical therapies, are fundamentally distinct at a biological level. This distinction clarifies why one of the conditions carries a markedly higher risk of developing colon cancer. The study’s findings suggest that the shared treatment approach may be inadequate and that disease‑specific strategies could be required to mitigate cancer risk.

AI summaries can be wrong sometimes—always verify important details using the source article.